Emergent Biosolutions Inc. · NYSE:EBS
Katkin Keith sold 15,481 Emergent Biosolutions Inc. shares (Form 4)
Traded Apr 30, 2026 · Filed May 4, 2026
On Apr 30, 2026, Katkin Keith (Director) sold 15,481 Emergent Biosolutions Inc. shares at US$8.28 for US$128K under a trading plan, leaving 96,294 shares. Filed May 4, 2026 (Form 4).
- Sold
- 15,481 shares
- Price
- US$8.28
- Value
- US$128K
- Holding after
- 96,294 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | Award | 25,344 | 111,775 | Direct | |
| Apr 30, 2026 | Common Stock | Sale | 15,481 | US$8.28 | 96,294 | Direct |
Source
Related
- Emergent Biosolutions Inc.
- Katkin Keith
- Emergent Biosolutions Inc. shareholders
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026